COVID-19: Trump Talks “Retaliation” If India Rejects Export Of Key Drug

Coronavirus: US President Donald Trump stated he spoke to PM Modi on Sunday.


  • Hydroxychloroquine is a key drug aged in the treatment of COVID-19
  • The centre presented a preserve on export of hydroxychloroquine on March 25
  • India is one amongst the enviornment’s greatest producers of the medication

Washington/ New Delhi:

US President Donald Trump has stated “there could perhaps well be retaliation” if India doesn’t agree to export hydroxychloroquine, a key anti-malaria drug believed by many to be effective in the treatment of coronavirus. His remarks come nearly two weeks after the authorities banned export of the drug as consultants test its efficacy in serving to treat COVID-19 patients.

“I could perhaps well be shocked if he (Top Minister Narendra Modi) would, you know, on fable of India does very successfully with the United States,” Mr Trump stated at a White Dwelling press briefing on Monday, when a reporter requested whether he used to be skittish about “retaliation to the US ban on export of clinical items” from India.

“I build no longer like that dedication, I didn’t hear that that used to be his dedication. I know that he stopped it for other nations. I spoke to him the day gone by, we had a actually apt focus on and we will gape whether or no longer that’s his… For loads of years, they’ve been taken profit of the United States on trade. So I could perhaps well be shocked if that had been his dedication. He’d must expose me that. I spoke to him Sunday morning, called him, and I stated, we’d fancy you allowing our provide to come out. If he doesn’t enable it to come out. That could perhaps well be OK. However of course, there could perhaps well be retaliation. Why wouldn’t there be,” the US President stated.

Trump has described hydroxychloroquine as a “sport-changer” although it’s yet to be established as an effective medication for COVID-19.

Closing month, the Indian Council of Medical Learn or ICMR had beneficial the use of hydroxychloroquine for treating healthcare workers serving coronavirus patients.

In a notification on March 25, the authorities presented a preserve on the medication’s export, alongside with that it could perhaps well be allowed only on “case-to case basis” on humanitarian grounds. India has reported over 4,000 coronavirus patients to this level and more than 100 deaths. 

This morning, alternatively, the authorities stated that key medication linked to COVID-19 medication shall be supplied to “nations which had been badly affected” by the pandemic.   

“In notice of the humanitarian aspects of the pandemic, it has been determined that India would licence paracetamol and Hydroxychloroquine in appropriate portions to all our neighbouring nations who are dependent on our capabilities. We are in a position to even be supplying these crucial medication to some nations who had been particularly badly littered with the pandemic. We would resulting from this truth discourage any speculation in this regard or any attempts to politicise the topic,” Foreign Ministry spokesperson Anurag Srivastava stated.

Currently, the US has the most number of coronavirus cases on the earth. The coronavirus demise count has crossed 10,000-mark in US; over 366,000 possess contracted an infection to this level.

Closing week, the US Meals and Drug Administration (FDA) issued an Emergency Thunder Authorization or EUA to enable the emergency use of hydroxychloroquine sulfate supplied from the nationwide stockpile to treat grownup and adolescent COVID-19 patients who weigh 50 kg or more and are hospitalised, per an dependable assertion.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *